Log In
Print this Print this

imalumab (BAX 069, Bax69)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant mAb targeting oxidized macrophage migration inhibitory factor (MIF)
Molecular Target Macrophage migration inhibitory factor (MIF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today